Incentive For New Drug Treatments

Links shared publicly online about this topic.

  • 881
    total visits

Incentive For New Drug Treatments

medicalnewstoday.com

Drug companies may be more willing to develop treatments for neglected diseases including malaria, tuberculosis and leishmanaiasis if the European Union would adopt a priority review voucher rew

View full resource at medicalnewstoday.com

Tags: Malaria, Tuberculosis, Disease and Condition, Drug, Pharma, disease

  • Share

Most Recently Shared on September 11, 2010 at 2:00 pm By:

Also Shared By:

MNT Transplants News MNT Transplants News

MNT Tuberculosis MNT Tuberculosis

TONIX Pharmaceuticals Completes Pharmacokinetic Study on New Formulation of TNX-102 for Fibromyalgia - Yahoo! Finance

finance.yahoo.com — “From Yahoo! Finance: Tonix Pharmaceuticals Holding Corp. , a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system completed a pharmacokinetic study of the first formulation of its lead drug, TNX-102, for the treatment of fibromyalgia syndrome .View full resource at finance.yahoo.com

  • View Related
  • Share

Most Recently Shared on April 6, 2012 at 2:01 am By:

Fibromyalgia_OW Fibromyalgia OW OW Health

TONIX Pharmaceuticals Completes Pharmacokinetic Study on New Formulation of TNX-102 for Fibromyalgia: Tonix Phar... http://t.co/pdPV40RY

1 week ago...

Cutting Malaria By 30 Per Cent Using Combination Drug Treatment

medicalnewstoday.com — “Malaria infections among infants can be cut by up to 30 per cent when antimalarial drugs are given intermittently over a 12 month period, a three-year clinical trial in Papua New Guinea has shown.View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 4, 2012 at 10:05 am By:

mnt_pediatrics MNT Pediatrics News Pediatrics and Health News

Cutting Malaria By 30 Per Cent Using Combination Drug Treatment http://t.co/v5vrauJx #pediatrics

1 week ago...

Eisai breast cancer drug still viewed as not cost effective by NICE - Pharmaceutical and Biotechnology News - Pharma Letter

thepharmaletter.com — “In a third rejection, the UK drug watchdog the National Institute for Health and clinical Excellence (NICE) has issued new guidance not recommending Halaven (eribulin), from Japanese drug major Eisai (TYO: 4523), for the treatment of locally advanced or mView full resource at thepharmaletter.com

  • View Related
  • Share

Most Recently Shared on April 3, 2012 at 12:13 pm By:

FiercePharma FiercePharma Health Site

Even w/discount MT @ThePharmaLetter: NICE still views Eisai breast cancer drug Halaven as not cost effective http://t.co/Bkd28AWx #pharma

2 weeks ago...

Scientists find new drug target for hard-to-treat leukaemia : Cancer Research UK

info.cancerresearchuk.org — “Cancer Research UK scientists have discovered a promising new approach to treat a type of myeloid leukaemia - a cancer with limited treatment options and relatively poor survival, according to research published in Cancer Cell today.View full resource at info.cancerresearchuk.org

  • View Related
  • Share

Most Recently Shared on March 29, 2012 at 5:30 pm By:

CR_UK Cancer Research UK Health Organization

Press release: @CR_UK scientists in Manchester find new drug target for hard-to-treat leukaemia http://t.co/LGweSaZC

2 weeks ago...

Research and Markets: Prostate Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010 - Yahoo! News

news.yahoo.com — “From Yahoo! News: Dublin - Research and Markets (http://www.researchandmarkets.com/research/4a4ba696/prostate_cancer) has announced the addition of GlobalData's new report "Prostate Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010" to their offering.View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on March 29, 2012 at 11:29 am By:

Cancer_PC Prostate Cancer OW OW Health

Research and Markets: Prostate Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010: Dublin -... http://t.co/NBrxcovX

2 weeks ago...

Symposier - Breast cancer research report from San Antonio | Dana-Farber Cancer Institute

symposier.com — “Uploaded and shared in Youtube by: DanaFarberCancerInst — Harold Burstein, MD, PhD, discusses several breast cancer research studies presented at the 2011 San Antonio Breast Cancer Symposium that he thinks are noteworthy but are not likely to generate media coverage, including two aromatase inhibitor studies that found that some women who had chemo-induced menopause did not benefit from the treatment because they regained their menstrual cycle; several studies that looked at the sexual health ofView full resource at symposier.com

  • View Related
  • Share

Most Recently Shared on March 29, 2012 at 5:59 am By:

SympoEndocrino Symposier Endocrino Health Site

Drugs targeting new pathways, sexual health of breast cancer PTs, chemo-induced menopause. http://t.co/l2BDjOH9

2 weeks ago...

FDA Targets ‘Cosmeceuticals’ Straddling Regulatory Lines - Businessweek

businessweek.com — “Wrinkle creams with retinol and a growing crop of beauty treatments that are partly pharmaceutical may need to be regulated as drugs, the top U.S. official overseeing the cosmetics industry said.View full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on March 28, 2012 at 5:35 pm By:

Bone Heath Improved By Everolimus Plus Exemestane In Post-Menopausal Women With Advanced Breast Cancer

medicalnewstoday.com — “Results from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women show that the combination of two cancer drugs, everolimus and exemestane, significantlView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 27, 2012 at 7:05 am By:

menopause_ow Menopause OW OW Health

Bone Heath Improved By Everolimus Plus Exemestane In Post-Menopausal Women With Advanced Breast Cancer: Results ... http://t.co/UZsEDAbO

3 weeks ago...

Few Young Women With Cancer Take Steps to Preserve Fertility - Drugs.com MedNews

drugs.com — “Very few young women with cancer take measures to preserve their fertility while undergoing cancer treatment, a new study says. The findings suggest that reprodView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 6:14 pm By:

drugscom Drugs.com Health Site

Few Young Women With Cancer Take Steps to Preserve Fertility - http://t.co/SVt51ycB

3 weeks ago...

Brain Tumors

fhcrc.org — “Fred Hutchinson Cancer Research Center scientists are making promising discoveries to advance the treatment of brain tumors-including medulloblastoma. Our scientists are developing new ways to remove brain cancer with “tumor paint,” finding new uses for existing drugs and discovering new therapies for tumors including natural and stem cell-based treatments.View full resource at fhcrc.org

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 5:38 pm By:

Few Young Women With Cancer Take Steps to Preserve Fertility - Drugs.com MedNews

drugs.com — “Very few young women with cancer take measures to preserve their fertility while undergoing cancer treatment, a new study says. The findings suggest that reprodView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 2:07 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Few Young Women With Cancer Take Steps to Preserve Fertility: MONDAY, March 26 -- Very few young women wit... http://t.co/MtZA1wlY #drug

3 weeks ago...

Cancer Cells Reprogrammed With Low Doses Of Epigenetic Drugs

medicalnewstoday.com — “Experimenting with cells in culture, researchers at the Johns Hopkins Kimmel Cancer Center have breathed possible new life into two drugs once considered too toxic for human cancer treatment. TheView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 7:05 am By:

mnt_leukemia MNT Leukemia Health News

Cancer Cells Reprogrammed With Low Doses Of Epigenetic Drugs http://t.co/dj68HJMj #lymphoma #leukemia

3 weeks ago...

Tenecteplase vs. Alteplase for Ischemic Stroke | Now@NEJM

blogs.nejm.org — “Though, for clinicians, ordering a drug these days is as simple as a click of a button, for the drug, getting to within reach of our fingertips is no easy feat.View full resource at blogs.nejm.org

  • View Related
  • Share

Most Recently Shared on March 25, 2012 at 4:13 pm By:

DrVes Ves Dimov, M.D. Physician, Doctor, Internist, and Allergist

Big step forward for tenecteplase on its road to becoming a new option for treatment of acute ischemic stroke - NEJM http://t.co/fHveM3Bc

3 weeks ago...

Little evidence for non-drug labor pain relief - EmpowHER.com

empowher.com — “NEW YORK (Reuters Health) - Epidurals and other drug-based treatments are the tried-and-tested way to ease labor pain, but also have side effectsView full resource at empowher.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 9:00 pm By:

Activists: Casual antibiotic use, inadequate treatment fuel drug-resistant TB in India - The Washington Post

washingtonpost.com — “NEW DELHI — India’s inadequate government-run tuberculosis treatment programs and a lack of regulation of the sale of drugs that fight the disease are responsible for the spiraling number of drug-resistant cases that are difficult to treat, health activists said Friday.View full resource at washingtonpost.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 9:41 am By:

tomheston Tom Heston, MD Doctor, Family Medicine Doctor, and Physician

Activists: Casual antibiotic use, inadequate treatment fuel drug-resistant TB ... - Wash... http://t.co/X3aOGmwe #medicine

3 weeks ago...

Advertisement